Skye Bio Obesity Drug Fails in Phase 2; Hopes Now Ride on Higher Doses and Combo Treatment
While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with…
Skye Bio Obesity Drug Fails in Phase 2; Hopes Now Ride on Higher Doses and Combo Treatment
While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo Nordisk’s Wegovy. Skye’s drug is an antibody designed to preferentially target CB1 receptors in the gut, offering an alternative approach to activating GLP-1…
Steps or Surgery: The Case for Wearables
Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it. The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.
Steps or Surgery: The Case for Wearables
Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it. The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.
The Tariff Opportunity for Medtech: Building the Supply Chain of the Future
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions. The post The Tariff Opportunity for Medtech: Building the Supply Chain…
The Tariff Opportunity for Medtech: Building the Supply Chain of the Future
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions. The post The Tariff Opportunity for Medtech: Building the Supply Chain…
A Look at Variation in Medicaid Spending Per Enrollee by Group and Across States
Because states have flexibility in designing their programs, state Medicaid spending and enrollment varies across states. This data note provides an overview of total Medicaid spending per enrollee by eligibility group and state.
A Look at Variation in Medicaid Spending Per Enrollee by Group and Across States
Because states have flexibility in designing their programs, state Medicaid spending and enrollment varies across states. This data note provides an overview of total Medicaid spending per enrollee by eligibility group and state.
GOP Falsely Ties Shutdown to Democrats’ Alleged Drive To Give All Immigrants Health Care
“Democrats are threatening to shut down the entire government because they want to give hundreds of billions of dollars of health care benefits to illegal aliens.” Vice President JD Vance in a Sept. 28, 2025, Fox News interview As the U.S. headed for a government shutdown, Republicans repeatedly accused Democrats of forcing the closure because…
Inside the High-Stakes Battle Over Vaccine Injury Compensation, Autism, and Public Trust
Department of Health and Human Services Secretary Robert F. Kennedy Jr. has floated a seismic idea: adding autism to the list of conditions covered by the Vaccine Injury Compensation Program. The program, known as VICP, provides a system for families to file claims against vaccine providers in cases in which they experience severe side effects….
Reaction to UHC Store: People Aren’t Saying ‘I Love My Health Insurer — Let Me See What Else I Can Buy From Them’
UnitedHealthcare launched UHC Store to sell discounted health services directly to members, but experts question whether consumers will embrace it. The post Reaction to UHC Store: People Aren’t Saying ‘I Love My Health Insurer — Let Me See What Else I Can Buy From Them’ appeared first on MedCity News.
